Cite
HARVARD Citation
Leroux-Roels, I. et al. (2023). Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial. Journal of infectious diseases. pp. 761-772. [Online].